These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 25652893)
1. Targeted gold nanoparticles enhance sensitization of prostate tumors to megavoltage radiation therapy in vivo. Wolfe T; Chatterjee D; Lee J; Grant JD; Bhattarai S; Tailor R; Goodrich G; Nicolucci P; Krishnan S Nanomedicine; 2015 Jul; 11(5):1277-83. PubMed ID: 25652893 [TBL] [Abstract][Full Text] [Related]
2. Radiosensitization of Prostate Cancers In Vitro and In Vivo to Erbium-filtered Orthovoltage X-rays Using Actively Targeted Gold Nanoparticles. Khoo AM; Cho SH; Reynoso FJ; Aliru M; Aziz K; Bodd M; Yang X; Ahmed MF; Yasar S; Manohar N; Cho J; Tailor R; Thames HD; Krishnan S Sci Rep; 2017 Dec; 7(1):18044. PubMed ID: 29273727 [TBL] [Abstract][Full Text] [Related]
3. Preclinical evaluation of gold-DTDTPA nanoparticles as theranostic agents in prostate cancer radiotherapy. Butterworth KT; Nicol JR; Ghita M; Rosa S; Chaudhary P; McGarry CK; McCarthy HO; Jimenez-Sanchez G; Bazzi R; Roux S; Tillement O; Coulter JA; Prise KM Nanomedicine (Lond); 2016 Aug; 11(16):2035-47. PubMed ID: 27463088 [TBL] [Abstract][Full Text] [Related]
4. Roadmap to Clinical Use of Gold Nanoparticles for Radiation Sensitization. Schuemann J; Berbeco R; Chithrani DB; Cho SH; Kumar R; McMahon SJ; Sridhar S; Krishnan S Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):189-205. PubMed ID: 26700713 [TBL] [Abstract][Full Text] [Related]
5. RGD-conjugated mesoporous silica-encapsulated gold nanorods enhance the sensitization of triple-negative breast cancer to megavoltage radiation therapy. Zhao N; Yang Z; Li B; Meng J; Shi Z; Li P; Fu S Int J Nanomedicine; 2016; 11():5595-5610. PubMed ID: 27822038 [TBL] [Abstract][Full Text] [Related]
7. The Role of Gold Nanorods in the Response of Prostate Cancer and Normal Prostate Cells to Ionizing Radiation-In Vitro Model. Musielak M; Boś-Liedke A; Piotrowski I; Kozak M; Suchorska W Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374960 [TBL] [Abstract][Full Text] [Related]
9. Molecularly targeted gold nanoparticles enhance the radiation response of breast cancer cells and tumor xenografts to X-radiation. Chattopadhyay N; Cai Z; Kwon YL; Lechtman E; Pignol JP; Reilly RM Breast Cancer Res Treat; 2013 Jan; 137(1):81-91. PubMed ID: 23160926 [TBL] [Abstract][Full Text] [Related]
11. Comparing gold nano-particle enhanced radiotherapy with protons, megavoltage photons and kilovoltage photons: a Monte Carlo simulation. Lin Y; McMahon SJ; Scarpelli M; Paganetti H; Schuemann J Phys Med Biol; 2014 Dec; 59(24):7675-89. PubMed ID: 25415297 [TBL] [Abstract][Full Text] [Related]
12. Gold nanoparticles for applications in cancer radiotherapy: Mechanisms and recent advancements. Her S; Jaffray DA; Allen C Adv Drug Deliv Rev; 2017 Jan; 109():84-101. PubMed ID: 26712711 [TBL] [Abstract][Full Text] [Related]
13. Targeted Gold Nanocluster-Enhanced Radiotherapy of Prostate Cancer. Luo D; Wang X; Zeng S; Ramamurthy G; Burda C; Basilion JP Small; 2019 Aug; 15(34):e1900968. PubMed ID: 31265213 [TBL] [Abstract][Full Text] [Related]
14. Quantitative analyses of amount and localization of radiosensitizer gold nanoparticles interacting with cancer cells to optimize radiation therapy. Hatoyama K; Kitamura N; Takano-Kasuya M; Tokunaga M; Oikawa T; Ohta M; Hamada Y; Tada H; Kobayashi Y; Kamei T; Gonda K Biochem Biophys Res Commun; 2019 Jan; 508(4):1093-1100. PubMed ID: 30551875 [TBL] [Abstract][Full Text] [Related]
15. Dose Rate Effects on the Selective Radiosensitization of Prostate Cells by GRPR-Targeted Gold Nanoparticles. Marques A; Belchior A; Silva F; Marques F; Campello MPC; Pinheiro T; Santos P; Santos L; Matos APA; Paulo A Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563666 [TBL] [Abstract][Full Text] [Related]
16. A simulation study on the radiosensitization properties of gold nanorods. Taheri A; Khandaker MU; Moradi F; Bradley DA Phys Med Biol; 2024 Feb; 69(4):. PubMed ID: 38286017 [No Abstract] [Full Text] [Related]
17. Uptake and excretion dynamics of gold nanoparticles in cancer cells and fibroblasts. Ivošev V; Sánchez GJ; Stefancikova L; Haidar DA; González Vargas CR; Yang X; Bazzi R; Porcel E; Roux S; Lacombe S Nanotechnology; 2020 Mar; 31(13):135102. PubMed ID: 31783387 [TBL] [Abstract][Full Text] [Related]
18. Gold nanoparticles, radiations and the immune system: Current insights into the physical mechanisms and the biological interactions of this new alliance towards cancer therapy. Dimitriou NM; Tsekenis G; Balanikas EC; Pavlopoulou A; Mitsiogianni M; Mantso T; Pashos G; Boudouvis AG; Lykakis IN; Tsigaridas G; Panayiotidis MI; Yannopapas V; Georgakilas AG Pharmacol Ther; 2017 Oct; 178():1-17. PubMed ID: 28322970 [TBL] [Abstract][Full Text] [Related]
19. Doxorubicin/gold-loaded core/shell nanoparticles for combination therapy to treat cancer through the enhanced tumor targeting. Kim K; Oh KS; Park DY; Lee JY; Lee BS; Kim IS; Kim K; Kwon IC; Sang YK; Yuk SH J Control Release; 2016 Apr; 228():141-149. PubMed ID: 26970205 [TBL] [Abstract][Full Text] [Related]
20. Ultrasmall Au(10-12)(SG)(10-12) nanomolecules for high tumor specificity and cancer radiotherapy. Zhang XD; Luo Z; Chen J; Shen X; Song S; Sun Y; Fan S; Fan F; Leong DT; Xie J Adv Mater; 2014 Jul; 26(26):4565-8. PubMed ID: 24817169 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]